Compare NCSM & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCSM | QSI |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.3M | 165.3M |
| IPO Year | 2017 | N/A |
| Metric | NCSM | QSI |
|---|---|---|
| Price | $73.00 | $0.76 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 26.1K | ★ 2.9M |
| Earning Date | 03-04-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 239.22 | N/A |
| EPS | ★ 8.65 | N/A |
| Revenue | ★ $142,471,000.00 | N/A |
| Revenue This Year | $5.57 | N/A |
| Revenue Next Year | $4.81 | $618.07 |
| P/E Ratio | $8.18 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.20 | $0.79 |
| 52 Week High | $75.57 | $3.10 |
| Indicator | NCSM | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 75.38 | 33.04 |
| Support Level | $33.92 | N/A |
| Resistance Level | N/A | $1.11 |
| Average True Range (ATR) | 5.63 | 0.06 |
| MACD | 0.44 | -0.01 |
| Stochastic Oscillator | 84.60 | 0.88 |
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.